American Association for Justice (AAJ) recently submitted comments to the Centers for Medicare and Medicaid Services (CMS) calling for more transparency of payments made to doctors and hospitals by drug and device manufacturers.
Financial relationships between drug and device manufacturers may result in a conflict of interest, as well as a negative impact on the safety of patients.
AAJ President Gary M. Paul stated: “We need to eliminate patients’ unnecessary exposure to potentially dangerous drugs and devices. Transparency will allow patients to determine whether their physicians have any conflicts of interest and empower them to make an informed decision regarding the drugs or devices they are prescribed.”
Learn more from AAJ’s full release.